Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effectiveness, Safety and Tolerability of RP-G28 in Subjects With Symptoms Associated With Lactose Intolerance

Trial Profile

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effectiveness, Safety and Tolerability of RP-G28 in Subjects With Symptoms Associated With Lactose Intolerance

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RP G28 (Primary)
  • Indications Lactose intolerance
  • Focus First in man; Proof of concept; Therapeutic Use
  • Sponsors Ritter Pharmaceuticals
  • Most Recent Events

    • 03 Jan 2017 According to a Ritter Pharmaceuticals media release, data from this trial published in Nutrition Journal Article 2013.
    • 03 Jan 2017 Results published in the Ritter Pharmaceuticals Media Release
    • 03 Jan 2017 According to a Ritter Pharmaceuticals media release, data from this trial published in the Proceedings of the National Academy of Science ("PNAS-Plus") PNAS 2017; Early Edition.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top